Prognostic significance of race and tumor size in carcinosarcoma of gallbladder: a meta-analysis of 68 cases.
Carcinosarcoma of gallbladder, also named sarcomatoid carcinoma and spindle cell carcinoma, is a rare neoplasm. Its clinical features and prognostic determinants are still poorly understood due to its rarity. We identified 67 qualified cases in published literatures and 1 in our institution. 52 of them were females and 16 males (F:M=3.25:1). 27 were Japanese patients and the rest were mainly from the United States and Europe. The mean age was 68.8 years (median 68 years, range 45-91 years). The average tumor size was 6.9 cm (median 5 cm, range 1.0-24.0 cm, n=49). Adenocarcinoma was the most common epithelial component (79.2%) and squamous cell carcinoma was the least common (9.4%). Spindle cell type was the most common mesenchymal component (44.6%) and osteoid was the least common (5.4%). The mean survival was 17.5 months (median 5 months, range 0 to 85 months, n=56). The 1-year and 5-year survival rates were 19+/-5% and 16+/-5% (mean+/-SD), respectively. Kaplan Meier survival analysis was conducted to examine the prognostic value of various clinical parameters. We found Japanese patients had longer survival time than non-Japanese ones (mean=19.9 months vs 11.5 months, median=6 vs 4 months, n=27 vs 24, p=0.022). Patients with smaller tumor (<5.0 cm) had longer survival time (in months) than those with larger tumor (mean 26.6 vs 17.7, median 11 vs 5, n=14 vs 27, p=0.028). The presence of gallstone, epithelial and mesenchymal component types, age and sex of the patients were not significant prognostic factors. In summary, race (Japanese vs non-Japanese) and tumor size are important prognostic factors in carcinosarcoma of gallbladder and they may be used for prognostification.
Zhang
Lanjing
L
Department of Pathology, Mount Sinai School of Medicine, New York, NY, USA.
Chen
Zheng
Z
Fukuma
Mariko
M
Lee
Lisa Y
LY
Wu
Maoxin
M
CA Cancer J Clin. 2001 Nov-Dec;51(6):349-64
11760569
Hum Pathol. 1999 Jan;30(1):21-5
9923922
Cancer. 1970 Mar;25(3):535-41
5416826
Exp Mol Pathol. 2006 Feb;80(1):67-71
15963980
Lancet Oncol. 2003 Mar;4(3):167-76
12623362
Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):297-301
9568784
J Pathol. 1971 Jun;104(2):145-8
5286390
J Gastroenterol. 2002;37(11):966-71
12483254
Cancer. 1992 Sep 15;70(6):1493-7
1516000
Semin Oncol. 2002 Dec;29(6 Suppl 20):17-22
12577229
Cancer. 1982 Sep 15;50(6):1166-70
7104957
J Hepatobiliary Pancreat Surg. 2006;13(5):468-71
17013725
Semin Diagn Pathol. 1993 May;10(2):176-87
8367625
J Hepatobiliary Pancreat Surg. 2002;9(5):569-75
12541042
Hum Pathol. 1993 Dec;24(12):1298-305
8276377
Mod Pathol. 1999 Aug;12(8):763-9
10463477
Arch Pathol Lab Med. 2003 Oct;127(10):e406-8
14521442
Cancer. 1984 May 15;53(10):2171-7
6704904
J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):439-43
10480335
J Gastrointest Surg. 2007 May;11(5):671-81
17468929